A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hong’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
Plans whose provider directory lists this clinician
Licensed to practise in California · since 2002 · expires 2028-01-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$14,776
Medicare paid this office $14,776 for 92 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Short return visit (20+ min)
37
$4,330
$82
Return visit (30+ min)
16
$2,111
$124
New patient visit (15+ min)
19
$1,028
$54
Cervical or vaginal cancer screening; pelvic and clinical breast examination
18
$867
$48
Short return visit
11
$562
$51
Who their Medicare patients are
92 Original Medicare patients in 2024. Average age 74 · Women 100% · Health risk score 0.76. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 45% · Depression 20% · Coronary heart disease 17% · Cancer 14%.
The office billed $61,093, Medicare allowed $19,865 and paid $14,776; for 169 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
92
169
74
0.76
$61,093
$14,776
2023
64
92
75
0.71
$33,150
$8,775
2022
42
65
73
0.69
$18,440
$5,197
2021
57
100
72
0.66
$35,231
$9,502
2020
52
100
72
0.92
$26,254
$6,735
2019
77
132
72
0.81
$40,896
$10,421
2018
69
122
70
0.91
$36,046
$8,186
2017
55
102
70
0.82
$28,850
$7,223
2016
56
96
72
0.81
$32,656
$7,865
2015
58
124
71
0.73
$36,529
$9,902
2014
47
97
72
0.77
$27,423
$6,859
2013
34
43
70
0.69
$10,919
$2,729
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
Original Medicare services billed in 2023
Short return visit (20+ min)
19
$2,132
$82
New patient visit (30+ min)
11
$1,204
$109
New patient visit (15+ min)
12
$796
$66
Cervical or vaginal cancer screening; pelvic and clinical breast examination
12
$587
$49
2022: 2 services
Original Medicare services billed in 2022
Short return visit (20+ min)
16
$1,721
$72
Cervical or vaginal cancer screening; pelvic and clinical breast examination
12
$581
$48
2021: 2 services
Original Medicare services billed in 2021
Short return visit (20+ min)
22
$2,345
$73
Cervical or vaginal cancer screening; pelvic and clinical breast examination
14
$686
$49
2020: 1 service
Original Medicare services billed in 2020
Short return visit (20+ min)
28
$2,376
$58
2019: 4 services
Original Medicare services billed in 2019
Short return visit (20+ min)
26
$2,632
$63
Return visit (30+ min)
11
$1,249
$104
New patient visit (15+ min)
17
$1,209
$71
Cervical or vaginal cancer screening; pelvic and clinical breast examination
17
$807
$47
2018: 4 services
Original Medicare services billed in 2018
Short return visit (20+ min)
20
$1,442
$55
Short return visit
15
$895
$39
Cervical or vaginal cancer screening; pelvic and clinical breast examination
16
$729
$46
New patient visit (15+ min)
11
$645
$59
2017: 2 services
Original Medicare services billed in 2017
Short return visit (20+ min)
22
$1,794
$64
Short return visit
11
$379
$27
2016: 2 services
Original Medicare services billed in 2016
Short return visit (20+ min)
18
$1,325
$58
Cervical or vaginal cancer screening; pelvic and clinical breast examination
13
$589
$45
2015: 4 services
Original Medicare services billed in 2015
Short return visit (20+ min)
23
$2,253
$64
New patient visit (15+ min)
15
$917
$61
Cervical or vaginal cancer screening; pelvic and clinical breast examination
16
$759
$47
Short return visit
12
$662
$44
2014: 2 services
Original Medicare services billed in 2014
Short return visit (20+ min)
15
$1,006
$67
Short return visit
11
$772
$35
2013: 1 service
Original Medicare services billed in 2013
Cervical or vaginal cancer screening; pelvic and clinical breast examination
14
$638
$46
Drugs they prescribed that Part D paid
$17,798
Pharmacies billed $17,798 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
99 generic and 33 brand-name prescriptions · $17,798 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Estradiol
48
$3,577
$75
Misoprostol
11
$14
$1
Year by year
Part D prescribing by year
2024
132
61
—None
25%
$17,798
2023
53
30
0% (0)
—None
$4,621
2022
57
19
0% (0)
26%
$7,217
2021
59
23
0% (0)
32%
$8,418
2020
71
28
0% (0)
38%
$12,198
2019
109
42
—None
37%
$18,566
2018
81
38
—None
38%
$11,604
2017
70
31
0% (0)
36%
$12,557
2016
71
34
—None
38%
$10,773
2015
79
33
—None
51%
$12,124
2014
76
29
—None
49%
$9,419
2013
48
20
0% (0)
58%
$7,407
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
Part D drugs prescribed in 2023
Estradiol
12
$1,370
$114
2022: 1 drug
Part D drugs prescribed in 2022
Fyavolv
11
$326
$30
2020: 1 drug
Part D drugs prescribed in 2020
Megestrol Acetate
11
$403
$37
2019: 4 drugs
Part D drugs prescribed in 2019
Estring
19
$8,386
$441
Estradiol
14
$1,931
$138
Triamcinolone Acetonide
14
$73
$5
Fluconazole
11
$38
$3
2018: 1 drug
Part D drugs prescribed in 2018
Estring
14
$6,000
$429
2017: 1 drug
Part D drugs prescribed in 2017
Estrace
16
$5,083
$318
2016: 1 drug
Part D drugs prescribed in 2016
Estrace
14
$4,031
$288
2015: 2 drugs
Part D drugs prescribed in 2015
Estring
15
$4,782
$319
Premarin
11
$2,819
$256
2014: 1 drug
Part D drugs prescribed in 2014
Estring
12
$3,268
$272
2013: 1 drug
Part D drugs prescribed in 2013
Premarin
11
$2,037
$185
Money from drug and device companies
$250 in 2024
Industry payments by year
2024
1
2
—None
$250
2019
1
1
—None
$53
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.